Abstract:The prenatal development of the neurons immunoreactive for high-affinity tropomycin-related kinase (trk) receptor (pan trk which recognizes trkA, trkB, and trkC) and low-affinity p75 neurotrophin receptor (p75NTR) was examined in the human brain from embryonic weeks 10 to 34 of gestation. In the embryonic week 10 specimen in which only brainstem regions were available for evaluation, trk immunoreactivity (trk-ir) was observed in the ventral cochlear, solitary, raphe, spinal trigeminal, and hypoglossal nuclei, … Show more
“…In layer 1, trkB TK+ mRNA-positive cells were observed throughout the postnatal life of humans. While the identity of the trkB TK+ mRNA-positive cells found in the human subcortical white matter or in layer I was not determined in our study, other groups have demonstrated that subplate neurons and layer I Cajal-Retzius (CR) cells express trkB in rodent brain, and that subplate neurons express pan-trk in the developing human brain (Cabelli et al, 1996;Chen et al, 1996;Fukumitsu et al, 1998;Ringstedt et al, 1998). Recent evidence suggests that CR cells continue to exist in the adult human prefrontal cortex (Martin et al, 1999).…”
Section: Expression Of Trkb Tk T In Dlpfc: Anatomymentioning
Signalling through tyrosine kinase receptor B (trkB) influences neuronal survival, differentiation and synaptogenesis. trkB exists in a full-length form (trkB(TK+)), which contains a catalytic tyrosine kinase (TK) domain, and a truncated form (trkB(TK-)), which lacks this domain. In the rodent brain, expression of trkB(TK+) decreases and trkBTK- increases during postnatal life. We hypothesized that both forms of trkB receptor mRNA would be present in the human neocortex and that the developmental profile of trkB gene expression in human may be distinct from that in rodent. We detected both trkB(TK+) and trkB(TK-) mRNA in RNA extracted from multiple human brain regions by Northern blot. Using in situ hybridization, we found trkB(TK+) mRNA in all cortical layers, with highest expression in layer IV and intermediate-to-high expression in layers III and V of the human dorsolateral prefrontal cortex. trkB(TK+) mRNA was present in neurons with both pyramidal and nonpyramidal shapes in the dorsolateral prefrontal cortex. trkB(TK+) mRNA levels were significantly increased in layer III in young adults as compared with infants and the elderly. In the elderly, trkB(TK+) mRNA levels were reduced markedly in all cortical layers. Unlike the mRNA encoding the full-length form of trkB, trkB(TK-) mRNA was distributed homogeneously across the grey matter, and trkB(TK-) mRNA levels increased only slightly during postnatal life. The results suggest that neurons in the human dorsolateral prefrontal cortex are responsive to neurotrophins throughout postnatal life and that this responsiveness may be modulated during the human lifespan.
“…In layer 1, trkB TK+ mRNA-positive cells were observed throughout the postnatal life of humans. While the identity of the trkB TK+ mRNA-positive cells found in the human subcortical white matter or in layer I was not determined in our study, other groups have demonstrated that subplate neurons and layer I Cajal-Retzius (CR) cells express trkB in rodent brain, and that subplate neurons express pan-trk in the developing human brain (Cabelli et al, 1996;Chen et al, 1996;Fukumitsu et al, 1998;Ringstedt et al, 1998). Recent evidence suggests that CR cells continue to exist in the adult human prefrontal cortex (Martin et al, 1999).…”
Section: Expression Of Trkb Tk T In Dlpfc: Anatomymentioning
Signalling through tyrosine kinase receptor B (trkB) influences neuronal survival, differentiation and synaptogenesis. trkB exists in a full-length form (trkB(TK+)), which contains a catalytic tyrosine kinase (TK) domain, and a truncated form (trkB(TK-)), which lacks this domain. In the rodent brain, expression of trkB(TK+) decreases and trkBTK- increases during postnatal life. We hypothesized that both forms of trkB receptor mRNA would be present in the human neocortex and that the developmental profile of trkB gene expression in human may be distinct from that in rodent. We detected both trkB(TK+) and trkB(TK-) mRNA in RNA extracted from multiple human brain regions by Northern blot. Using in situ hybridization, we found trkB(TK+) mRNA in all cortical layers, with highest expression in layer IV and intermediate-to-high expression in layers III and V of the human dorsolateral prefrontal cortex. trkB(TK+) mRNA was present in neurons with both pyramidal and nonpyramidal shapes in the dorsolateral prefrontal cortex. trkB(TK+) mRNA levels were significantly increased in layer III in young adults as compared with infants and the elderly. In the elderly, trkB(TK+) mRNA levels were reduced markedly in all cortical layers. Unlike the mRNA encoding the full-length form of trkB, trkB(TK-) mRNA was distributed homogeneously across the grey matter, and trkB(TK-) mRNA levels increased only slightly during postnatal life. The results suggest that neurons in the human dorsolateral prefrontal cortex are responsive to neurotrophins throughout postnatal life and that this responsiveness may be modulated during the human lifespan.
“…In particular, ChAT-positive, p75-negative neurons have been reported in the nucleus basalis-substantia innominata complex, whose fibers have been surmised to project to the amygdala and parts of the rhinal paralimbic areas (Heckers et al 1994). An absence or decrease in the p75 receptor has been demonstrated in the amygdala of rodents (Yan and Johnson 1988) as well as in the entorhinal cortex of humans (Kordower and Mufson 1992;Chen et al 1996). This may explain the relative sparing of ChAT observed in immunotoxintreated animals in the entorhinal-piriform cortex and the amygdala (Heckers et al 1994;Schliebs et al 1996).…”
Changes in brain electrical activity in response to cholinergic agonists, antagonists, or excitotoxic lesions of the basal forebrain may not be reflective entirely of changes in cholinergic tone, in so far as these interventions also involve noncholinergic neurons. We examined electrocortical activity in rats following bilateral intracerebroventricular administration of 192 IgG-saporin (1.8 μg/ventricle), a selective cholinergic immunotoxin directed to the low-affinity nerve growth factor receptor p75. The immunotoxin resulted in extensive loss of choline acetyl transferase (ChAT) activity in neocortex (80%-84%) and hippocampus (93%), with relative sparing of entorhinalpiriform cortex (42%) and amygdala (28%). Electrocortical activity demonstrated modest increases in 1-to 4-Hz power, decreases in 20-to 44-Hz power, and decreases in 4-to 8-Hz intraand interhemispheric coherence. Rhythmic slow activity (RSA) occurred robustly in toxin-treated animals during voluntary movement and in response to physostigmine, with no significant differences seen in power and peak frequency in comparison with controls. Physostigmine significantly increased intrahemispheric coherence in lesioned and intact animals, with minor increases seen in interhemispheric coherence. Our study suggests that: (1) electrocortical changes in response to selective cholinergic deafferentation are more modest than those previously reported following excitotoxic lesions; (2) changes in cholinergic tone affect primarily brain electrical transmission within, in contrast to between hemispheres; and (3) a substantial
“…It is known that CGRP-expressing primary afferent neurons, serotonergic neurons in the Raphe nuclei, noradrenergic neurons of the locus ceruleus and dopaminergic neurons of the hypothalamus all express p75 in several species, including humans (Sobreviela et al, 1994;Berg-von der Emde et al, 1995;Wright & Snider, 1995;Chen et al, 1996;Yamuy et al, 2000), implicating a possible direct role for p75 NTR in suppressing spinal plasticity. TH-expressing axons in the substantia nigra pars compacta, some of which also project spinally, do not express p75 NTR (Chaisuksunt et al, 2003) so, if these axons sprout after rhizotomy and ⁄ or neurotrophic factor treatment, the underlying mechanism is likely to be p75 NTR independent.…”
Section: Discussionmentioning
confidence: 99%
“…The present results represent the first report of decreased spinal innervation by descending monoaminergic axons in p75-⁄ -mice. While these axonal phenotypes are known to express p75 NTR (Sobreviela et al, 1994;Berg-von der Emde et al, 1995;Chen et al, 1996;Yamuy et al, 2000), it remains unknown whether the decrease in spinal axon density is due to a developmental decrease in neuronal number and ⁄ or to a decrease in spinal branching.…”
Axonal plasticity in the adult spinal cord is governed by intrinsic neuronal growth potential and by extracellular cues. The p75 receptor (p75(NTR)) binds growth-promoting neurotrophins (NTs) as well as the common receptor for growth-inhibiting myelin-derived proteins (the Nogo receptor) and so is well situated to gauge the balance of positive and negative influences on axonal plasticity. Using transgenic mice lacking the extracellular NT-binding domain of p75(NTR) (p75-/- mice), we have examined the influence of p75(NTR) on changes in the density of primary afferent (calcitonin gene-related peptide-expressing) and descending monoaminergic (serotonin- and tyrosine hydroxylase-expressing) projections to the dorsal horn after dorsal rhizotomy, with and without concomitant application of exogenous nerve growth factor and NT-3. We found that, in intact p75-/- mice, the axon density of all populations was equal to or less than that in wild-type mice but that rhizotomy-induced intraspinal sprouting was significantly augmented. Monoaminergic axon sprouting was enhanced in both nerve growth factor- and NT-3-treated p75-/- mice compared with similarly treated wild-type mice. Primary afferent sprouting was particularly robust in NT-3-treated p75-/- mice. These in vivo results illustrate the interactions of p75(NTR) with NTs, with their respective tropomyosin-related kinase receptors and with inhibitory myelin-derived molecules. Our findings illustrate the pivotal role of p75(NTR) in spinal axonal plasticity and identify it as a potential therapeutic target for spinal cord injury.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.